We focus on optimizing the diagnostics and management of children suffering from diseases in the musculoskeletal system. Two main areas are growth plate lesions and dysplastic hips and feet. For more information, please visit our website,

We combine epidemiological basic science with research in assessment, diagnostics and new treatment programmes to develop rational strategies for prevention and treatment of functional disorders in children and adolescents. A key issue is to translate our findings into clinical practice.

I work as a stroke physician at Department of Neurology at Aarhus University Hospital. My research interest is mainly on prehospital triage of patients with acute stroke. Also, I am interested in peri-procedual management of endovascular therapy.

We study pituitary hormones and diseases with a special focus on growth hormone (GH). We focus on effects of GH and insulin on substrate metabolism and insulin sensitivity. We do studies in patients with acromegaly and GH-deficiency, pituitary-adrenal axis disorders and gluocorticoid excess.

We study mechanisms in the neurobiology of mental health disorders, in particular Gut-Brain interactions, the role of food components, atypical neurotransmitters, and rapid-acting drugs. We examine behaviour, in vivo neurochemistry, molecular/cellular biology, and morphology in advanced models.

Our goal is to study neuroprotection methods and improve prehospital organization and acute revascularization treatment leading to better life after stroke. Our research group build on a strong and well-established cross-disciplinary collaboration.

My research group works on the mechanisms of ALS, polyneuropathy and criticial illness myopathy, and earlier diagnosis of these using novel methods. We are pionering the development and implementation of cortical excitability testing with TMS, muscle/nerve excitability testing and MScanFit MUNE.

We investigate changes in cells and molecules primarily in the central and peripheral nervous system. We use cultured cells, transgenic animal models and samples from patients combined with methods from advanced light and electron microscopy, molecular biology, genetics and stereology.

We trace uncertainties of prognostics and decision making in unresponsive patients with serious brain injury between scientific and clinical reasoning. Studying knowledge relationality in an interdisciplinary team with outset in anthropology and medical humanities. See also:

We are interested in the somatosensory nervous system and the pathophysiology and therapy of neuropathic pain. We focus on translational and clinical research including mechanism-based clinical trials.
See also Danish Pain Research Centre

The research goal of my team is to use different types of brain scans and other advanced neuroimaging techniques to understand the brain changes occurring in Parkinson’s and other neurodegenerative diseases. We aim to identify targets for new therapeutic strategies, including neuromodulation surgery.

My lab aims to understand how and when Parkinson’s disease begins. We employ advanced multi-modal imaging studies of patient cohorts including PET, SPECT & MRI, histology studies of patient brain and gut tissues, and mechanistic studies in experimental animal models.

Main Research is clinical interventions for ADHD, OCD and Tourette Syndrome, and research in outreach programmes. Both non-pharmacological interventions for children with ADHD, cognitive behavioural therapy for OCD and Tourette's Syndrome as well as add-on projects on neuropsychological aspects and genetics are in focus.

We develop, implement and validate neurophysiological methods in clinical practice. Main topics: automated seizure detection, electromagnetic source imaging, nerve and muscle excitability and ultrasound. See also:

We use biophysical modelling and MRI to develop techniques to study the structure of the brain on a micrometer scale. Our work enables subtle changes in microstructure of the living brain to be visualized noninvasively, with applications for e.g. earlier diagnostics of neurodegenerative diseases.

Associate Professors

Smell is a key contributor to flavour of food and social interaction. For the 15% of the population suffering from smell loss, the importance of smell is evident. We aim to create better understanding of smell, why smell loss occurs, and how to treat or alleviate the negative impact of smell loss.

We use PET imaging to study in vivo the biochemical changes in novel rodent and minipig animal models of neuropsychiatric and neurodegenerative disorders. We examine efficacy of putative therapeutics (neuroprotectants, stem cells, brain stimulation) as a prelude to human imaging studies.

Neurogenic orthostatic hypotension is a red flag for a significant underlying disease. Our focus is at present on Parkinsons disease, diabetes, and TTR-amyloidosis. We can evaluate peripheral small fibre sensory and autonomic function and monitor the cardiovagal and cardiovascular adrenergic system.

My research is focused on depression and novel treatment strategies. My studies are translational including animal models of depression and human samples – integrating behavioral, molecular, and pharmacological approaches. The main goals are better treatment and identification of biomarkers.

Methodology for electrodiagnosis of neuromuscular diseases with special emphasis on diagnostic criteria for amyotrophic lateral sclerosis. The use of quantitative neurophysiological methods including electroencephalographic reactivity for prognostication of comatose patients.

The overall aim of our research is to improve our understanding of the molecular mechanisms behind psychiatric disease. We are specifically interested in investigating the relationship between inflammation and depression with a view to develop alternative pharmacological treatment strategies.

Our work concerns the use of Gottingen minipig as a model animal in neurosurgery and neuroscience. In my research, I focus on studying the anatomy and histology of the minipig brain, as well as describing brain tissue reaction in various disease models and after using different treatment modalities.

We are interested in the role of ultrasound in neuromuscular diseases. We investigate the usefulness of ultrasound as a tool to understand nerve/muscle pathology, alongside electrodiagnosis , in entrapments neuropathies, traumatic /inflammatory nervelesions, and amyotrophic lateral sclerosis.

Our research focuses on the molecular correlates of treatment response to rapid acting antidepressants with particular emphasis on ketamine and psilocybin. We are also focusing on protein-protein interactions regulating the trafficking and function of the sortilin receptor and the serotonin transporter.

To provide best evident treatment, we investigate high and lowtech solutions for neurorehabilitation in classical neurological disorders, spinal cord injuries and minor CNS injuries. We stand on a multidisciplinary platform with national/international partners at The SCIWDK, Dept Neurology Viborg.

Can we improve rehabilitation for people with acquired brain injuries? My research focuses on technology-assisted rehabilitaion, specifically Brain Computer Interfaces to restore upper limb function after stroke. Furthermore, I work with digital behavior as a means of health monitoring.

My research area is cerebrovascular disease and dementia aiming to identify new strategies to target prevention, and modifying the progression, of cerebrovascular disease, including stroke, and subsequent dementia. We study capillary dysfunction on MRI, diet, genetics, and extracellular vesicles.

We investigate blood-brain signalling with a focus on acute stroke and the neurovascular coupling using molecular tools and advanced imaging techniques. This includes studies of molecular changes in acute stroke, neuroprotective molecules, and how systemic signals affect the neurovascular coupling.

Our research group conducts basic science and clinical consciousness research. In our current main line of research, we use MRI based to build neuroarchitectural models with the aim of providing exhaustive explanations for a range of phenomena in conscious perception and related cognitive functions.

My research focus on all aspects of eating disorders (binge eating disorders, anorexia and bulimia nervosa) but especially assessment, diagnostics, treatment outcome, involuntary treatment including clinical and register based studies.

My research partly focuses on cognitive impairment in primarily neurodegenerative diseases and partly on the highly interdisciplinary field of human-technology interaction. The latter spans from Internet-delivered intervention research to basic research into social cognition and implicit biases in relation to interactions with social robots.

We develop novel biomarkers for PET imaging. A current focus is imaging neuropeptides such as oxytocin and neuropeptide Y for the first time in human. We couple this work with analysis of plasma hormones. We apply these methods to study effects of food and oral contraceptives on brain and behaviour.

Research fields (aim): Spinal cord injury (reduce the primary and secondary pathophysiological process), the degenerative spine (individualized treatment) and congenital and acquired spinal cord malformations (improve diagnostics and treatment in the pathology and surrounding cerebro-spinal fluid).

We study 1) the comorbidity between mental disorders and somatic diseases, particularly immune-related diseases and whether inflammation relates to a subgroup of mental disorders, and 2) the effect of different psychopharmacological and anti-inflammatory medications on severe mental disorders.

We focus on changes in the peripheral nervous system (PNS), especially on understanding why some patients develop neuropathic pain, aiming to identify novel treatment targets. We use e.g. skin biopsies combined with advanced microscopy, molecular biology, genetics and stereology.

Our research is driven by a strong interest in understanding how early life environment interacts with (epi)genetic structures, modify cognitive, immune and metabolic development and increases the risk for neuropsychiatric disorders, including addiction, later in life.

We develop methods to measure brain changes based on MRI and other imaging modalities that allow us to understand disease processes and quantify their progression in various brain disorders. We have a particular focus on neurodegenerative diseases, such as Alzheimer, Parkinson, and multiple sclerosis.

Our research is primarily on various clinical aspects of the psychopathology of mood disorders, electroconvulsive therapy, psychopharmacology, and the association with physical illness.

Our research group is interested in identifying risk factors related to the development of persistent symptoms after acute whiplash trauma and understanding the mechanisms within the biopsychosocial model in the recovery. We include questionnaires, clinical examinations, and register data.

Neuromarkers helping in a clinical seeting to estimat neuronal damage are most needed. E.g. neurofilaments are proteins selectively expressed in the cytoskeleton of neurons, and increased levels are a marker of axonal damage. We investigate the role and need in various nerve injuries and diseases.

I do research on social cognition which is the ability to interact socially, e.g. to infer the feelings and intentions of other people. I investigate ways to assess and treat social cognitive deficits in people with schizophrenia and in autism spectrum disorders.

We investigate risk factors in early life for neuro- or psychiatric disorders. The ongoing project is on neonatal hyperbilirubinemia and its short and long-term consequences on neurological development. This may contribute to understanding the extent and frequency of Kernicterus Spectrum Disorder.

Assistant Professors and Postdocs

We investigate linguistic and other cognitive deficits, as well as their amelioration, in Parkinson’s disease and other patient groups by employing advanced neuroimaging techniques (i.e. MEG, EEG, tractography) in combination with patient-tailored experimental designs.

Our aim is to create a wearable seizure alarm for patients with epilepsy. The alarm system is based on heart rate variability measured with wearable electrocardiography (ECG). The seizure alarm will be a vital asset for patients enabling caregivers to take necessary precautions during seizures.

Our research focuses on the investigation of pathogenic processes in Parkinson’s disease (PD) using experimental animal models and human patient tissue. We employ histology, behavioral testing of PD rodent models, PET/MRI imaging and tracer studies to evaluate disease progression.